Microneedle arrays as medical devices for enhanced transdermal drug delivery

Expert Review of Medical Devices

Volumn 8, Issue 4, 2011, Pages 459-482

  Garland, Martin J ^a   Migalska, Katarzyna ^a   Mahmood, Tuan Mazlelaa Tuan ^a   Singh, Thakur Raghu Raj ^a   Woolfson, A David ^a   Donnelly, Ryan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

drug monitoring; microneedle arrays; public perception; safety; transdermal drug delivery; vaccination

Indexed keywords

DRUG MONITORING; MICRONEEDLE ARRAYS; PUBLIC PERCEPTION; TRANSDERMAL DRUG DELIVERY; VACCINATION;

BIODEGRADABLE POLYMERS; BIOMEDICAL ENGINEERING; DRUG DELIVERY; PATIENT MONITORING; SUGARS;

NEEDLES;

BIOPOLYMER; METAL; SILICON; SUGAR;

AQUEOUS SOLUTION; DEVICE; DRUG DELIVERY SYSTEM; MICROTECHNOLOGY; NEEDLE; REVIEW;

ADMINISTRATION, CUTANEOUS; COATED MATERIALS, BIOCOMPATIBLE; DRUG DELIVERY SYSTEMS; EQUIPMENT AND SUPPLIES; HUMANS; MICROINJECTIONS; NEEDLES;

EID: 79960101183     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.11.20     Document Type: Review

References (114)

1. Banga AK. Therapeutic Peptides and Proteins: Formulation, Processing and Delivery Systems. CRC Press, FL, USA (2006).
2. Gupta H, Sharma A. Recent trends in protein and peptide drug delivery systems. Asian J. Pharm. 3, 69-75 (2009).
3. Tanner T, Marks R. Delivering drugs by the transdermal route: review and comment. Skin Res. Technol. 14, 249-260 (2008).
4. Coulman S, Allender C, Birchall J. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit. Rev. Ther. Drug. 23, 205-258 (2006). (Pubitemid 44950092)
5. Wiechers J W. The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm. Weekbl. Sci. 11, 185-198 (1998).
6. Kaushik S, Allen H, Donald D et al. Lack of pain associated with microfabricated microneedles. Anesth. Analg. 92, 502-504 (2001). (Pubitemid 32127644)
7. Prausnitz MR. Microneedles for transdermal drug delivery. Adv. Drug Deliv. Rev. 56, 581-587 (2004). (Pubitemid 38326934)
8. Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 87, 922-925 (1998). (Pubitemid 28381247)
9. Martanto W, Davis SP, Holiday NR, Wang J, Gill H, Prausnitz MR. Transdermal delivery of insulin using microneedles in vivo. Pharm. Res. 21, 947-952 (2004). (Pubitemid 38870143)
10. Donnelly RF, Morrow DIJ, McCarron PA et al. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J. Control. Release 129, 154-162 (2008).
11. Gill H, Prausnitz M. Coated microneedles for transdermal delivery. J. Control. Release 117, 227-237 (2007). (Pubitemid 46161873)
12. Gill H, Prausnitz M. Coating formulations for microneedles. Pharm. Res. 24, 1369-1280 (2007).
13. Lee JW, Park JH, Prausnitz MR. Dissolving microneedles for transdermal drug delivery. Biomaterials 29, 2113-2124 (2008).
14. Park JH, Allen MG, Prausnitz MR. Polymer microneedles for controlled-release drug delivery. Pharm. Res. 23, 1008-1019 (2006). (Pubitemid 43781409)
15. Davis S, Martanto W, Allen M, Prausnitz M. Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans. Biomed. Eng. 52, 909-915 (2005). (Pubitemid 40675490)
16. McAllister D, Wang P, Davis S et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc. Natl Acad. Sci. USA 100, 13755-13760 (2003). (Pubitemid 37499139)
17. Xie Y, Xu B, Gao Y. Controlled transdermal delivery of model drug compounds by MEMS microneedle array. Nanomed. Nanotechnol. 1, 184-190 (2005). (Pubitemid 43963615)
18. Wilke N, Mulcahy A, Ye S, Morrissey A. Process optimization and characterization of silicon microneedles fabricated by wet etch technology. Microelectronics J. 36, 650-656 (2005). (Pubitemid 40973306)
19. Zafar SR, Thwar PK, Yang M, Ugaz VM, Burns MA. Integrated microsystems for controlled drug delivery. Adv. Drug Deliv. Rev. 56, 185-189 (2004).
20. Ziaie B, Baldi A, Lei M, Gu Y, Siegel RA. Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery. Adv. Drug Deliv. Rev. 56, 145-148 (2004).
21. Cormier M, Johnson B, Ameri M et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. J. Control. Release 97, 503-511 (2004). (Pubitemid 38802952)
22. Verbaan FJ, Bal SM, Van den DJB et al. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J. Control. Release 128, 80-88 (2008). Highlights the importance of a reliable application method to enable reproducible microneedle insertion.
23. Mikszta JA, Dekker JP, Harvey NG, Dean CH, Brittingham JM. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect. Immun. 74, 6806-6810 (2006). (Pubitemid 44913155)
24. Donnelly R, Morrow D, McCarron P et al. Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer. Photochem. Photobiol. 85, 195-204 (2009).
25. Ding Z, Verbaan F, Bivas B et al. Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. J. Control. Release 136, 71-78 (2009).
26. Bal S, Ding Z, Kersten G, Jiskoot W, Bouwstra J. Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphteria toxoid formulations. Pharm. Res. 27, 1837-1847 (2010).
27. Pearton M, Allender C, Brain K et al. Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations. Pharm. Res. 25, 407-416 (2007). (Pubitemid 351257969)
28. Wei-Ze L, Mei-Ronga H, Jian-Pinga Z et al. Super-short solid silicon microneedles for transdermal drug delivery applications. Int. J. Pharm. 389, 122-129 (2010).
29. Qiu Y, Gao Y, Hu K, Li F. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J. Control. Release 129, 144-150 (2008).
30. Chen H, Zhu H, Zheng J et al. Iontophoresis driven penetration of nanovesicles through microneedle induced skin microchannels for enhancing transdermal delivery of insulin. J. Control. Release 139, 63-72 (2009).
31. Wermeling D, Banks S, Hudson D et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc. Natl Acad. Sci. USA 105, 2058-2063 (2008). (Pubitemid 351439464)
32. Trautmann A, Heuck F, Mueller C, Ruther P, Paul O. Replication of microneedle arrays using vacuum casting and hot embossing. Presented at: 13th International Conference on Solid-State Sensors, Actuators and Microsystems, Seoul, Korea, 5-9 June 2005.
33. Oh JH, Park HH, Do KY et al. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein. Eur. J. Pharm. Biopharm. 69, 1040-1045 (2008).
34. Dean CH, Alarcon JB, Waterson AM et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax-JE) in non-human primates. Hum. Vaccin. 1, 106-111 (2005).
35. Mikszta JA, Sullivan VJ, Dean CH et al. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J. Infect. Dis. 191, 278-288 (2005). (Pubitemid 40096387)
36. Laurent PE, Bourhy H, Fantino M, Alchas P, Mikszta JA. Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. Vaccine 28, 5850-5856 (2010).
37. Chen X, Prow T, Crichton M et al. Dry-caoted microprojection array patches for targeted delivery of immunotherapeutics to the skin. J. Control. Release 139, 212-220 (2009).
38. Banga A. Microporation applications for enhancing drug delivery. Expert Opin. Drug Deliv. 6, 343-354 (2009).
39. Zhu Q, Zarnistyn V, Ye L et al. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc. Natl Acad. Sci. USA 106, 7968-7973 (2009).
40. Gill H, Söderholm J, Prausnitz M, Sllberg M. Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther. 17, 811-814 (2010).
41. Matriano JA, Cormier M, Johnson J et al. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm. Res. 19, 63-70 (2002). (Pubitemid 34075108)
42. Widera G, Johnson J, Kim L et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 24, 1653-1664 (2006). (Pubitemid 43238242)
43. Sathyan G, Sun Y, Weyers R, Daddona P, Staehr P, Gupta S. Macroflux® desmopressin transdermal delivery system: pharmacokinetic and pharmacodynamic evaluation in healthy volunteers. AAPS J. 6(Suppl. 1), 665 (2004) (Abstract).
44. Daddona P, Matriano J, Mandem J, Maa Y. Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm. Res. 28(1), 159-165 (2011).
45. Han M, Kim D, Seong H et al. Improvement in antigen-delivery using fabrication of a grooves-embedded microneedle array. Sens. Actuators B Chem. 137, 274-280 (2009).
46. Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J. Control. Release 104, 51-66 (2005). (Pubitemid 40615235)
47. Prausnitz MR, Langer R. Transdermal drug delivery. Nat. Biotechnol. 26, 1261-1268 (2008).
48. Perennes F, Marmiroli B, Matteucci M, Tormen M, Vaccari L, Fabrizio E. Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol. J. Micromech. Microeng. 16, 473-479 (2006). (Pubitemid 43289723)
49. Sammoura F, Kang JJ, Heo YM, Tae SJ, Liwei L. Polymeric microneedle fabrication using a microinjection molding technique. Microsyst. Technol. 13, 517-522 (2007). (Pubitemid 46324428)
50. Lippmann J, Geiger E, Pisano A. Polymer investment molding: Method for fabricating hollow, microscale parts . Sens. Actuators A Phys. 134, 2-10 (2007). (Pubitemid 46321598)
51. Sullivan SP, Murthy N, Prausnitz MR. Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv. Mater. 20, 933-938 (2008).
52. Aoyagi S, Hayato I, Yuichi I, Mitsuo F, Ogawa H. Laser fabrication of high aspect ratio thin holes on biodegradable polymer and its application to a microneedle. Sens. Actuators A Phys. 139, 293-302 (2007). (Pubitemid 47314198)
53. Han M, Hyun DH, Park HH, Lee SS, Kim CH, Kim CG. A novel fabrication process for out-of-plane microneedle sheets of biocompatible polymer. J. Micromech. Microeng. 17, 1184-1191 (2007). (Pubitemid 46838934)
54. Chu L, Choi S, Prausnitz M. Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: bubble and pedestal microneedle designs. J. Pharm. Sci. 99, 4228-4238 (2010).
55. Donnelly RF, Majithiya R, Singh TRR et al. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm. Res. 28, 41-57 (2011).
56. Donnelly RF, Morrow DIJ, Thakur RRS et al. Processing difficulties and instability of carbohydrate microneedle arrays. Drug Dev. Ind. Pharm. 35, 1242-1254 (2009).
57. Kolli C, Banga A. Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm. Res. 25, 104-113 (2008).
58. Miyano T, Tobinaga Y, Takahiro K et al. Sugar micro needles as transdermic drug delivery system. Biomed. Microdevices 7, 185-188 (2005). (Pubitemid 41236286)
59. Miyano T, Miyachi T, Okanishi T et al. Hydrolytic microneedles as transdermal drug delivery system. Proceedings of the 14th International Conference on Solid-State Senors, Actuators and Microsystems. Lyon, France, 10-14 June 2007, 1, 355-358 (2007).
60. Li G, Badkar A, Nema S, Kolli CS, Banga AK. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int. J. Pharm. 368, 109-115 (2009).
61. Li G, Badkar A, Kalluri H, Banga A. Microchannels created by sugar and metal microneedles: Characterization by microscopy, macromolecular flux and other techniques. J. Pharm. Sci. 99, 1931-1941 (2010).
62. Ito Y, Eiji H, Atsushi S, Nobuyuki S, Kanji T. Feasibility of microneedles for percutaneous absorption of insulin. Eur. J. Pharm. Sci. 29, 82-88 (2006). (Pubitemid 44279397)
63. Ito Y, Ohashi Y, Saeki A, Sugioka N, Takada K. Antihyperglycemic effect of insulin from self-dissolving micropiles in dogs. Chem. Pharm. Bull. 56, 243-246 (2008). (Pubitemid 351463230)
64. Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K. Sustained-release self-dissolving micropiles for percutaneous absorption on insulin in mice. J. Drug Target. 15, 323-326 (2007). (Pubitemid 46887862)
65. Ito Y, Yoshmitsu J, Shiroyama K, Sugioka N, Takada K. Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J. Drug Target. 14, 255-261 (2006). (Pubitemid 44173291)
66. Ito Y, Saeki A, Shiroyama K, Sugioka N, Takada K. Percutaneous absorption of interferon-a by self-dissolving micropiles. J. Drug Target. 16, 243-249 (2008). (Pubitemid 351460653)
67. Ito Y, Ohashi Y, Shiroyama K, Sugioka N, Takada K. Self-dissolving micropiles for the percutaneous absorption of recombinant human growth hormone in rats. Biol. Pharm. Bull. 31, 1631-1633 (2008).
68. Ito Y, Hasegawa R, Fukushima K, Sugioka N, Takada K. Self-dissolving micropile array chip as percutaneous delivery system of protein drug. Biol. Pharm. Bull. 33, 683-690 (2010).
69. Fukushima K, Ise A, Morita H et al. Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats. Pharm. Res. 28, 7-21 (2011).
70. Kwon SY. In vitro evaluation of transdermal drug delivery by a microneedle patch. Controlled Release Society 31st Annual Meeting Transactions. TheraJect Inc., no. 115 (2004).
71. Sullivan SP, Koutsonanos DG, Del Pilar Martin M et al. Dissolving polymer microneedle patches for influenza vaccination. Nat. Med. 16, 915-921 (2010).
72. Roxhed N, Patrick G, Stemme G. Membrane-sealed hollow microneedles and related administration schemes for transdermal drug delivery. Biomed. Microdevices 10, 271-279 (2008). (Pubitemid 351337929)
73. Bodhale W, Nisar A, Afzulpurka N. Structural and microfluidic analysis of hollow side-open polymeric microneedles for transdermal drug delivery applications. Microfluid. Nanofluid. 8, 373-392 (2010).
74. Martanto W, Moore J, Kashlan O et al. Microinfusion using hollow microneedles. Pharm. Res. 23, 104-113 (2006). (Pubitemid 43214666)
75. Gardeniers H, Luttge R, Berenschot E et al. Silicon micromachined hollow microneedles for transdermal liquid transport. J. Microelectomech. Syst. 12, 855-862 (2003).
76. Stoeber B, Liepmann L. Two-dimensional arrays of out-of-plane needles. Proc. ASME MEMS Div. IMECE 1, 355-359 (2000).
77. Griss P, Stemme G. Side-opened out-of-plane microneedles for microfluidic transdermal liquid transfer. J. Microelectomech. Syst. 12, 296-301 (2003).
78. Martanto W, Moore JS, Couse T, Prausnitz MR. Mechanism of fluid infusion during microneedle insertion and retraction. J. Control. Release 112, 357-361 (2006). (Pubitemid 43737149)
79. Roxhed N, Gasser C, Griss P, Holzapfel GA, Stemme G. Penetration enhanced ultrasharp microneedles and prediction on skin interaction for efficient transdermal drug delivery. J. Microelectromech. Syst. 16, 1429-1440 (2007). (Pubitemid 350239136)
80. Wang PM, Cornwell M, Hill J, Prausnitz MR. Precise microinjection into skin using hollow microneedles. J. Invest. Dermatol. 126, 1080-1087 (2006).
81. Roxhed N, Samel B, Nordquist L, Griss P, Stemme G. Painless drug delivery through microneedle-based transdermal patches featuring active infusion. IEEE Trans. Biomed. Eng. 55, 1063-1071 (2008). (Pubitemid 351301214)
82. Chandrasekaran S, Brazzle JD, Frazier AB. Surface micromachined metallic microneedles. J. Microelectromech. Syst. 12, 281-288 (2003).
83. Chandrasekaran S, Frazier AB. Characterization of surface micromachined metallic microneedles. MEMS IEEE 16th Annual International Conference, 363-366 (2003).
84. Sammoura F, Kang JJ, Heo YM, Tae SJ, Liwei L. Polymeric microneedle fabrication using a microinjection molding technique. Microsyst. Technol. 13, 517-522 (2007). (Pubitemid 46324428)
85. Ovsianikov A, Chichkov B, Mente P, Monteiro-Riviere N, Doraiswamy A, Narayan R. Two photon polymerization of polymer-ceramic hybrid materials for transdermal drug delivery. Int. J. Appl. Ceramic Tech. 4, 22-29 (2007). (Pubitemid 46189573)
86. Nordquist L, Roxhed N, Griss P, Stemme G. Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration. Pharm. Res. 24, 93-100 (2007).
87. Gupta J, Felner E, Prausnitz M. Minimally invasive insulin delivery in subjects with Type 1 diabetes using hollow microneedles. Diabetes Technol. Ther. 11, 329-337 (2009).
88. Sivamani R, Stoeber B, Liepmann D, Maibach H. Microneedle penetration and injection past the stratum corneum in humans. J. Dermatol. Treat. 20, 156-159 (2009).
89. Sivamani R, Stoeber B, Wu G, Zhai H, Liepmann D, Maibach H. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration. Skin Res. Technol. 11, 152-156 (2005). (Pubitemid 40542856)
90. Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27, 454-459 (2009).
91. Laurent PE, Bonnet S, Alchas P et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25, 8833-8842 (2007). (Pubitemid 350192056)
92. Mikszta JA, Dekker JP, Harvey NG et al. Microneedle based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect. Immun. 6806-6810 (2006). (Pubitemid 44913155)
93. Belshe RB, Newman FK, Cannon J et al. Serum antibody responses after intradermal vaccination against influenza. N. Engl. J. Med. 351, 2286-2294 (2004). (Pubitemid 39552744)
94. Alarcon JB, Hartley AW, Harvey NG, Mikszta JA. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin. Vacc. Immun. 14, 375-381 (2007). (Pubitemid 46732547)
95. Ji J, Tay F, Miao J, Iliescu C. Microfabricated microneedles with porous tip for drug delivery. J. Micromech. Microeng. 16, 958-964 (2006). (Pubitemid 43797618)
96. Davis SP, Landis BJ, Adams ZH, Allen MG, Prausnitz MR. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J. Biomechanics 37, 1155-1163 (2004). (Pubitemid 38798369)
97. Verbaan F, Bal S, Van den Berg D et al. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J. Control. Release 117, 238-245 (2007). (Pubitemid 46161879)
98. Park, JH, Yoon YK, Choi SO, Prausnitz MR, Allen MG. Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery. IEEE Trans. Biomed. Eng. 54, 903-913 (2007). (Pubitemid 46628570)
99. Yamamoto T, Yamamoto Y. Electrical properties of the epidermal stratum corneum. Med. Biol. Eng. Comput. 14, 151-158 (1976).
100. Donnelly RF, Garland MJ, Morrow DIJ et al. Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. J. Control. Release 147, 333-341 (2010).
101. Crichton ML, Ansaldo A, Chen X, Prow TW, Fernando GJP, Kendall MAF. The effect of strain rate on the precision of penetration of short densely packed microprojection array patches coated with vaccine. Biomaterials 31(16), 4562-4572 (2010).
102. Coulman S, Birchall J, Alex A et al. In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography. Pharm. Res. 28(1), 66-81 (2011).
103. Enfield J, OConnell ML, Lawlor K, Jonathan E, OMahony C, Leahy M. In vivo dynamic characterization of microneedle skin penetration using optical coherence tomography. J. Biomed. Opt. 15(4), 046001 (2010).
104. Bal SM, Caussin J, Pavel S, Bouwstra JA. In vivo assessment of safety microneedle arrays in human skin. Eur. J. Pharm. Sci. 35, 193-202 (2008).
105. Haq M, Smith E, John D et al. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed. Microdevices 11, 35-47 (2009).
106. Kalluri H, Banga AK. Formation and closure of microchannels in skin following microporation. Pharm. Res. 28, 82-94 (2011).
107. Donnelly RF, Thakur R, Tunney M et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm. Res. 26, 2513-2522 (2009).
108. Birchall J, Clemo R, Anstey A, John D. Microneedles in clinical practice - an explanatory study into the views and opinions of healthcare professionals and the public. Pharm. Res. 28, 95-106 (2011).
109. Thakur RRS, Dunne NJ, Cunningham E, Donnelly RF. Review of patents on microneedle applicators. Recent Pat. Drug Deliv. Formul. 5, 11-23 (2011).
110. Wang PM, Cornwell M, Prausnitz MR. Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. Diab. Tech. Ther. 7, 131-141 (2005). (Pubitemid 40354583)
111. Gerstel MS, Place VA. US patent US3964482 (1976).
112. Zosano Pharma: presentations www.zosanopharma.com/index. php?option=com-content&task=blogcateg ory&id=26&Itemid=169 (Accessed 17 January 2011)
113. NanoPass Technologies Ltd www.nanopass.com (Accessed 17 January 2011)
114. 3M Microneedle Technology http://solutions.3m.com/wps/portal/3M/en-WW/ DrugDeliverySystems/DDSD/technology-solutions/transdermal-technologies/ microstructured-transdermal-systems/(Accessed 17 January 2011)